Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Recent release: Blog examines faith-based response to HIV/AIDS

In a post in KPLU's "Humanosphere" blog, journalist Tom Paulson discusses the role of faith-based organizations in the response to HVI/AIDS, writing, "PEPFAR is mentioned in perhaps every other speech here at the International AIDS Conference, AIDS 2012, as one of those game-changers. Infrequently, some folks also mention, usually just in passing, something like the 'contributions of the faith-based community.'

27 Jul 2012

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

Gilead Sciences, Inc. announced today its results of operations for the quarter ended June 30, 2012.

26 Jul 2012

First Edition: July 26, 2012

Today's headlines include coverage of findings from a new study that indicate Medicaid may help people live longer.

26 Jul 2012

Recent release: Blogs discuss advancements in HIV preventative, therapeutic R&D

In this post in the Center for Global Health Policy's "Science Speaks" blog, IAVI President and CEO Margaret McGlynn, AVAC Executive Director Mitchell Warren and UNAIDS Executive Director Michel Sidibe highlight the release of a report from the HIV Vaccine & Microbicides Resource Tracking Working Group.

26 Jul 2012

Bill Gates stresses importance of investment in both HIV treatment and research for vaccines, microbicides

In a symposium session on Monday at the XIX International AIDS Conference in Washington, D.C., politicians and public health experts joined Bill & Melinda Gates Foundation Co-Chair Bill Gates for a discussion about improving effectiveness and efficiency in the HIV/AIDS response, the Washington Post reports.

25 Jul 2012

First Edition: July 24, 2012

Today's headlines include news from the campaign season as well as reports from the international AIDS conference currently taking place in Washington, D.C.

24 Jul 2012

NIDA announces recipients of 2012 Avant-Garde Award for HIV/AIDS Research

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, today announced the recipients of the 2012 Avant-Garde Award for HIV/AIDS Research. The three scientists, Drs. David Smith, Samuel Friedman and Jeremy Luban, will each receive $500,000 per year for five years to support their research.

24 Jul 2012

Views on AIDS: Despite advances, still no cure, no vaccine, and indifference grows

The story of the AIDS pandemic has been grim for so long that optimism seems hardly possible. But as the 19th International AIDS conference opens in Washington on Sunday, there is hope for control of a disease that has killed nearly 35 million people over three decades and 1.7 million in the past year.

23 Jul 2012

Implementing multifaceted global effort may help end global HIV/AIDS pandemic

Ending the global HIV/AIDS pandemic may be possible by implementing a multifaceted global effort that expands testing, treatment, and prevention programs, as well as meets the scientific challenges of developing an HIV vaccine and possibly a cure, according to a Viewpoint in the July 25 issue of JAMA, a theme issue on HIV/AIDS.

23 Jul 2012

All adult patients with HIV should be offered ART: International Antiviral Society-USA panel

Included in the 2012 International Antiviral Society-USA panel recommendations for human immunodeficiency virus (HIV) patient care is that all adult patients, regardless of CD4 cell count, should be offered antiretroviral therapy (ART), according to an article in the July 25 issue of JAMA, a theme issue on HIV/AIDS.

23 Jul 2012

BioDiem presents positive findings of their eye disease drug at international conference

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced positive results from formal studies of its BDM-E eye disease drug, presented over 21 – 22 July at the International Society for Eye Research (ISER) meeting in Berlin, Germany. The ISER convenes leading researchers and clinicians in the area of eye disease.

22 Jul 2012

International HIV/AIDS funding to African nations inadequate, MSF says

"African nations are not receiving adequate international funding to fight HIV/AIDS, leaving them to face catastrophic consequences without enough medication, an independent, global medical and humanitarian organization said Thursday," the Associated Press reports.

21 Jul 2012

New CHAIT initiative on development of novel immunological therapeutic interventions

The CHAIT initiative is a public-private partnership focusing on the development of novel immunological therapeutic interventions to achieve a 'functional HIV cure' with the ultimate goal of HIV eradication.

21 Jul 2012

Natural compound can virtually eradicate HIV in infected culture cells

A new study by scientists on the Florida campus of The Scripps Research Institute shows, in cell culture, a natural compound can virtually eliminate human immunodeficiency virus (HIV) in infected cells. The compound defines a novel class of HIV anti-viral drugs endowed with the capacity to repress viral replication in acutely and chronically infected cells.

20 Jul 2012

Viewpoints: Researchers see potential to control HIV pandemic; The 'ceaseless attacks' on women's reproductive health

We are at a moment of extraordinary optimism in the response to the human immunodeficiency virus (HIV). A series of scientific breakthroughs ... have the potential to markedly expand the available preventive tools. There is evidence of the first cure of an HIV-infected person. And most important, the finding that early initiation of antiretroviral therapy can both improve individual patient outcomes and reduce the risk of HIV transmission to sexual partners by 96% has led many to assert what had so long seemed impossible: that control of the HIV pandemic may be achievable.

20 Jul 2012

BioDiem signs agreement with RMIT to create new non-influenza vaccines

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced that BioDiem has signed an agreement with The Royal Melbourne Institute of Technology (RMIT) regarding a research program that will investigate the use of BioDiem’s live attenuated influenza virus (LAIV) to create new non-influenza vaccines. Developing the potential of the LAIV technology for new indications is an important part of BioDiem’s strategy, and this research is part of the work towards that goal.

19 Jul 2012

Drug treatments, scientific advances fuel hope for HIV control as AIDS 2012 conference draws near

"A cure for AIDS remains a distant prospect but a host of drug treatments and other advances have fueled fresh hope that new HIV infections may someday be halted for good," Agence France-Presse reports.

17 Jul 2012

AIDS 2012 conference to discuss problem of HIV in Black community

In a series of presentations, panel discussions, and training sessions at the 2012 International AIDS Conference (AIDS2012), the Black AIDS Institute (The Institute) will bring together leaders in medicine, politics, journalism, and the arts to discuss the problem of HIV/ AIDS in the Black Community.

16 Jul 2012

International AIDS Conference must focus on combination prevention strategies to fight AIDS among women

Highlighting statistics showing how HIV affects more women than men worldwide, Serra Sippel, president of the Center for Health and Gender Equity (CHANGE), writes in a Huffington Post "Global Motherhood" blog post, "The XIX International AIDS Conference is coming to Washington, D.C., in two weeks and it must be different from its predecessors for one reason: HIV is now a woman's plague."

13 Jul 2012

PLoS Medicine papers examine HIV treatment as prevention

Early treatment with antiretroviral medication can significantly reduce the risk of HIV transmission to an uninfected sexual partner, "but many logistical hurdles stand in the way of making this strategy feasible, affordable and effective, according to experts writing in Tuesday's edition of the journal PLoS Medicine," the Los Angeles Times reports.

12 Jul 2012

Pandemic News and Research

Further Reading

Recent release: Blog examines faith-based response to HIV/AIDS

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

First Edition: July 26, 2012

Recent release: Blogs discuss advancements in HIV preventative, therapeutic R&D

Bill Gates stresses importance of investment in both HIV treatment and research for vaccines, microbicides

First Edition: July 24, 2012

NIDA announces recipients of 2012 Avant-Garde Award for HIV/AIDS Research

Views on AIDS: Despite advances, still no cure, no vaccine, and indifference grows

Implementing multifaceted global effort may help end global HIV/AIDS pandemic

All adult patients with HIV should be offered ART: International Antiviral Society-USA panel

BioDiem presents positive findings of their eye disease drug at international conference

International HIV/AIDS funding to African nations inadequate, MSF says

New CHAIT initiative on development of novel immunological therapeutic interventions

Natural compound can virtually eradicate HIV in infected culture cells

Viewpoints: Researchers see potential to control HIV pandemic; The 'ceaseless attacks' on women's reproductive health

BioDiem signs agreement with RMIT to create new non-influenza vaccines

Drug treatments, scientific advances fuel hope for HIV control as AIDS 2012 conference draws near

AIDS 2012 conference to discuss problem of HIV in Black community

International AIDS Conference must focus on combination prevention strategies to fight AIDS among women

PLoS Medicine papers examine HIV treatment as prevention

Best practices - optimize qPCR processes for pathogen detection eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News